New Technology Innovations to Propel Cell-Based Diagnostic Market to $9 Billion by 2011,

PRLog (Press Release) – Jan 18, 2008 – Report Buyer, the online destination for business intelligence for major industry sectors, has now added a new report showing that cell-based diagnostics with applications in heamatology, histology, cytology, microbiology, and transplant medicine generated more than $6 billion in revenues last year, and new and innovative enabling technologies are emerging that will propel certain segments of the market forward at double-digit rates

“Cell-Based Diagnostics: Technology, Application and Markets”(http://www.reportbuyer.com/KAL00102) evaluates the market for both traditional technologies such as heamatology, flow cytometry, and traditional stains, as well as increasingly sophisticated molecular techniques and the emerging areas of rare cell event testing, microarrays and beadarrays. These new technologies and digital arrays carry the advantage of being well suited to feed data to software designed to interpret array patterns and create the test result.

The report shows that these innovations and new methods for genotyping biopsied tissue could revolutionise the treatment of a number of diseases, including: diabetes, cancer, and autoimmune and neurodegenerative diseases and could lead the way to an era of individualised patient therapies using techniques such as microarrays, biochips, PCR and in situ hybridisation.

Authors of the report note that the potential for these technologies is huge. The market is based on commercialised assays and reagents, but there is also a vast menu of in-lab developed, or ‘home-brew’ tests using tissue stains, flow reagents, antibodies, molecular probes and dyes marketed by scores of companies, worldwide.

“Cell-Based Diagnostics: Technology, Application and Markets” reviews technologies available and in development from nearly 200 companies and discusses the impact of cell-based diagnostics on patient care, as well as in drug discovery and development research. Analysis of market trends and market forecasts for twelve cell diagnostic segments are also provided.

“Cell-Based Diagnostics: Technology, Application and Markets” is available from Report Buyer. For more information go to: http://www.reportbuyer.com/pharma_healthcare/diagnostics ...

Report Buyer product ID: KAL00102